StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) stock

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 14/3010% below fair value
$433.93−12.35 (-2.77%)

Close on Nov 17, 2026Market cap $93.75BP/E 18.5Yield –

Elevance Health r&d expenses

Research and development expenses are spending on new products and technology.

No r&d expenses figures for Elevance Health

Elevance Health has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Elevance Health figures

See a number that looks wrong?